Several studies indicated that GPCRs through interactions with cannabinoid receptors [24], neuropeptide receptors [25], histamine receptors [26] and chemokine receptors [27] may likely play therapeutic roles in IBD. This evidence concerns the gene NPSR1 and inflammatory bowel disease.